✦ LIBER ✦

Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens

✍ Scribed by Zheng, Y.; Hughes, M. D.; Lockman, S.; Benson, C. A.; Hosseinipour, M. C.; Campbell, T. B.; Gulick, R. M.; Daar, E. S.; Sax, P. E.; Riddler, S. A.; Haubrich, R.; Salata, R. A.; Currier, J. S.

Book ID: 125513984
Publisher: University of Chicago Press
Year: 2014
Tongue: English
Weight: 292 KB
Volume: 59
Category: Article
ISSN: 1058-4838
DOI: 10.1093/cid/ciu367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High virologic response rate after secon

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting

✍ Thanyawee Puthanakit, Gonzague Jourdain, Piyarat Suntarattiwong, Kulkanya Chokep 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 195 KB

Effectiveness of Boosted Protease Inhibi

Effectiveness of Boosted Protease Inhibitor-Based Regimens in HIV Type 1-Infected Patients Who Experienced Virological Failure with NNRTI-Based Antiretroviral Therapy in a Resource-Limited Setting

✍ Siripassorn, Krittaecho; Manosuthi, Weerawat; Chottanapund, Suthat; Pakdee, Aran 📂 Article 📅 2010 🏛 Mary Ann Liebert 🌐 English ⚖ 705 KB

Immuno-haematologic and virologic respon

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

✍ Meriki, Henry D; Tufon, Kukwah A; Afegenwi, Mbunkah H; Nyindem, Bernard A; Atang 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 280 KB

A qualitative PCR minipool strategy to s

A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy

✍ Newman, Howard; Breunig, Lukas; van Zyl, Gert; Stich, August; Preiser, Wolfgang 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 620 KB

Effects of nucleoside reverse transcript

Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients

✍ A Hill; W Sawyer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Low rate of virological failure and main

Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice

✍ Mattia C.F. Prosperi; Maurizio Zazzi; Grazia Punzi; Laura Monno; Grazia Colao; P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract Protease inhibitor (PI)‐resistant HIV‐1 has hardly ever been detected at failed boosted PI‐based first‐line antiretroviral regimens in clinical trials. However, this phenomenon has not been investigated in clinical practice. To address this gap, data from patients starting a first‐line